Dysfunction of the PI3K-AKT/mTOR signaling has been associated with various psychiatric disorders, including depression and anxiety, and the antidepressant actions of some fast-acting and long-lasting antidepressants, such as ketamine, require the activation of the mTOR pathway [140]. This evidence concerns the gene MTOR and depressive symptom measurement.